COX-2 Inhibitor Discontinuation Before Hip Replacement
COX-2 inhibitors do not need to be discontinued before hip replacement surgery and can actually be beneficial when given preoperatively. 1
Evidence-Based Recommendation
The 2021 PROSPECT guidelines for total hip arthroplasty explicitly recommend continuing COX-2 inhibitors perioperatively rather than holding them 1. The evidence shows:
Preoperative Administration is Beneficial
- Oral etoricoxib given 2 hours before surgery or IV parecoxib/oral celecoxib given 1 hour before surgery significantly reduced postoperative pain scores and morphine consumption compared to placebo 1
- Pre-incisional COX-2 administration showed superior pain control up to 6 hours postoperatively and reduced morphine consumption up to 24 hours compared to post-incisional administration 1
No Need to Discontinue
The 2005 PROSPECT guidelines note that injectable parecoxib remains available for short-term perioperative use in treating postoperative pain 2. Research directly supports this: a 2007 study on celecoxib in knee replacement (transferable to hip) concluded "It is not necessary to discontinue celecoxib before surgery" as it did not increase perioperative blood loss 3.
Important Caveats
Bleeding Risk Considerations
While COX-2 inhibitors are safer than traditional NSAIDs regarding bleeding:
- Traditional NSAIDs (like diclofenac) significantly increase perioperative blood loss - one study showed 32% increased blood loss with diclofenac versus only 7% with rofecoxib 4
- COX-2 selective inhibitors have minimal impact on platelet function, unlike non-selective NSAIDs 2
Cardiovascular Considerations
Both guidelines emphasize using COX-2 inhibitors with caution in patients with known cardiovascular disease 2. However, this is a consideration for use versus non-use, not a timing issue for discontinuation.
Clinical Algorithm
For patients currently on COX-2 inhibitors:
- Continue through surgery - no discontinuation needed
- Consider giving preoperative dose 1-2 hours before surgery for optimal pain control
- Combine with paracetamol as part of multimodal analgesia 1
Contraindications to perioperative use (not timing-related):
- Active cardiovascular disease (myocardial infarction, unstable angina)
- Aspirin-sensitive asthma
- Active gastric ulcers (though less concern with COX-2 vs traditional NSAIDs)
This contrasts sharply with traditional NSAIDs, which should be stopped 1-10 days preoperatively depending on the specific agent 5.